InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in InMed Pharmaceuticals Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 5
- −9 vs. Q3 2024
- Shares held
- 48.9K
- −1.09M (−95.7%) vs. Q3 2024
- Total value
- $226.7K
- −$39.3K (−14.8%) vs. Q3 2024
- New holders
- 1
- 0 more added
- Sold out
- 10
- 4 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $4.18M |
| Q1 2026 | 9 | $206.0K |
| Q4 2025 | 7 | $240.7K |
| Q3 2025 | 9 | $665.2K |
| Q2 2025 | 7 | $28.5K |
| Q1 2025 | 5 | $13.3K |
| Q4 2024 | 5 | $226.7K |
| Q3 2024 | 15 | $266.0K |
| Q2 2024 | 14 | $116.6K |
| Q1 2024 | 18 | $249.2K |
| Q4 2023 | 17 | $334.4K |
| Q3 2023 | 10 | $18.6K |
| Q2 2023 | 10 | $14.5K |
| Q1 2023 | 15 | $109.4K |
| Q4 2022 | 14 | $234.4K |
| Q3 2022 | 15 | $876.9K |
| Q2 2022 | 18 | $514.5K |
| Q1 2022 | 19 | $341.9K |
| Q4 2021 | 18 | $536.4K |
| Q3 2021 | 19 | $979.9K |
| Q2 2021 | 20 | $2.99M |
| Q1 2021 | 22 | $1.55M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding InMed Pharmaceuticals Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 38,460 | $177.3K | 0.03% | −694,836−94.8% | Reduced |
| UBS Group AG | 10,408 | $49.3K | 0.00% | −201,631−95.1% | Reduced |
| AllSquare Wealth Management LLC | 1 | $5 | 0.00% | −20−95.2% | Reduced |
| Federation des caisses Desjardins du Quebec | 1 | $5 | 0.00% | −18−94.7% | Reduced |
| Danske Bank A/S | 1 | $5 | 0.00% | +1 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −56,666−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −50,296−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −38,369−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −28,415−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −22,611−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Gables Capital Management Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Banque Cantonale Vaudoise | – | – | – | – | Not filed |